Press "Enter" to skip to content

New patent for Bioxcel drug IGALMI

0
Copyright © DrugPatentWatch. Originally published at New patent for Bioxcel drug IGALMI

Annual Drug Patent Expirations for IGALMI
Annual Drug Patent Expirations for IGALMI

Igalmi is a drug marketed by Bioxcel and is included in one NDA. There is one patent protecting this drug.

This drug has twenty patent family members in twelve countries.

The generic ingredient in IGALMI is dexmedetomidine hydrochloride. Additional details are available on the dexmedetomidine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Bioxcel drug IGALMI
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions